ACQUISITION OF BENEFICIAL OWNERSHIP

Company

UroGen Pharma Ltd.

Filed

October 4, 2019

Accession Number

0001387131-19-007448

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →